Found: 15
Select item for more details and to access through your institution.
A multidisciplinary neuro-oncological triage panel reduces the time to referral and treatment for patients with a brain tumor.
- Published in:
- Neuro-Oncology Practice, 2021, v. 8, n. 5, p. 559, doi. 10.1093/nop/npab040
- By:
- Publication type:
- Article
Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach?
- Published in:
- 2023
- By:
- Publication type:
- Editorial
A Negative Body Image among Adolescent and Young Adult (AYA) Cancer Survivors: Results from the Population-Based SURVAYA Study.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5243, doi. 10.3390/cancers14215243
- By:
- Publication type:
- Article
Learning from long‐term adolescent and young adult (AYA) cancer survivors regarding their age‐specific care needs to improve current AYA care programs.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 12, p. 13712, doi. 10.1002/cam4.6001
- By:
- Publication type:
- Article
Reducing severe fatigue in patients with diffuse glioma: a study protocol for an RCT on the effect of blended cognitive behavioural therapy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
First‐line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid.
- Published in:
- Epilepsia (Series 4), 2021, v. 62, n. 5, p. 1119, doi. 10.1111/epi.16880
- By:
- Publication type:
- Article
Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohort.
- Published in:
- Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdad149
- By:
- Publication type:
- Article
The STELLAR trial: a phase II/III randomized trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma.
- Published in:
- Brain Communications, 2024, v. 6, n. 4, p. 1, doi. 10.1093/braincomms/fcae241
- By:
- Publication type:
- Article
Health-related quality of life of Adolescent and Young Adult Cancer Survivors before and during the COVID-19 pandemic: longitudinal improvements on social functioning and fatigue.
- Published in:
- Journal of Patient-Reported Outcomes, 2023, v. 7, n. 1, p. 1, doi. 10.1186/s41687-023-00629-0
- By:
- Publication type:
- Article
Health-related quality of life of Adolescent and Young Adult Cancer Survivors before and during the COVID-19 pandemic: longitudinal improvements on social functioning and fatigue.
- Published in:
- Journal of Patient-Reported Outcomes, 2023, v. 7, n. 1, p. 1, doi. 10.1186/s41687-023-00629-0
- By:
- Publication type:
- Article
The effectiveness of antiepileptic drug treatment in glioma patients: lamotrigine versus lacosamide.
- Published in:
- Journal of Neuro-Oncology, 2021, v. 154, n. 1, p. 73, doi. 10.1007/s11060-021-03800-z
- By:
- Publication type:
- Article
Patient-Reported Outcomes of Accelerated Aging: A Novel Approach to Investigate Second Cancer Risk in Adolescent and Young Adult (18−39 Years) Cancer Survivors.
- Published in:
- Oncologist, 2024, v. 29, n. 4, p. e526, doi. 10.1093/oncolo/oyad307
- By:
- Publication type:
- Article
Long-term wellbeing and neurocognitive functioning of diffuse low-grade glioma patients and their caregivers: A longitudinal study spanning two decades.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 2, p. 351, doi. 10.1093/neuonc/noac185
- By:
- Publication type:
- Article
Patients with primary brain tumors and COVID-19: A report from the Dutch Oncology COVID-19 Consortium.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 2, p. 326, doi. 10.1093/neuonc/noab258
- By:
- Publication type:
- Article
Recruiting Adolescent and Young Adult Cancer Survivors for Patient-Reported Outcome Research: Experiences and Sample Characteristics of the SURVAYA Study.
- Published in:
- Current Oncology, 2022, v. 29, n. 8, p. 5407, doi. 10.3390/curroncol29080428
- By:
- Publication type:
- Article